Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bonfiglio, G.
Right arrow Articles by Stefani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonfiglio, G.
Right arrow Articles by Stefani, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 115-117
© 2000 The British Society for Antimicrobial Chemotherapy

Brief reports

Levofloxacin in vitro activity and time–kill evaluation of Stenotrophomonas maltophilia clinical isolates

Giovanni Bonfiglioa,*, Carmela Casconea, Cinzia Azzarellia, Viviana Cafisoa, Federico Marchettib and Stefania Stefania

a Dipartimento di Scienze Microbiologiche, Università di Catania, via Androne 81, 95124 Catania and b Direzione Medica GlaxoWellcome S.p.A., Verona, Italy

The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 104 and 106 cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but only 58.3% were susceptible to ofloxacin; at the higher inoculum, 78.3% were susceptible to levofloxacin and 36.7% to ofloxacin. In time–kill studies, levofloxacin exerted bactericidal activity within 4 h. With ofloxacin and ciprofloxacin bacterial regrowth was observed after 8 h. Levofloxacin may represent an alternative drug in the treatment of infections caused by S. maltophilia.

* Corresponding author. Tel: +39-095-311352; Fax: +39-095-325032; E-mail: bonfigio{at}mbox.unict.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. C. Nicodemo, M. R. E. Araujo, A. S. Ruiz, and A. C. Gales
In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods
J. Antimicrob. Chemother., April 1, 2004; 53(4): 604 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
G. P. Gesu, F. Marchetti, L. Piccoli, and A. Cavallero
Levofloxacin and Ciprofloxacin In Vitro Activities against 4,003 Clinical Bacterial Isolates Collected in 24 Italian Laboratories
Antimicrob. Agents Chemother., February 1, 2003; 47(2): 816 - 819.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. L. Cohn and K. B. Waites
Antimicrobial Activities of Gatifloxacin against Nosocomial Isolates of Stenotrophomonas maltophilia Measured by MIC and Time-Kill Studies
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 2126 - 2128.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.